Craig Lynch

Predicting outcomes of pelvic exenteration using machine learning.

undefined PelvEx Collaborative

Journal article  |  2020  |  Colorectal Dis

AIM: We aim to compare machine learning with neural network performance in predicting R0 resection (R0), length of stay > 14 days ..

Simultaneous pelvic exenteration and liver resection for primary rectal cancer with synchronous liver metastases: results from the PelvEx Collaborative.

undefined PelvEx Collaborative

Journal article  |  2020  |  Colorectal Dis

AIM: At presentation, 15-20% of patients with rectal cancer already have synchronous liver metastases. The aim of this study was t..

Re-do cytoreductive surgery for peritoneal surface malignancy: Is it worthwhile?

Vignesh Narasimhan, Francis Cheung, Peadar Waters, Oliver Peacock, Satish Warrier, Craig Lynch, Michael Michael, Robert Ramsay, Alexander Heriot

Journal article  |  2020  |  SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND

BACKGROUND AND OBJECTIVES: Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) offers selected pati..

The global cost of pelvic exenteration: in-hospital perioperative costs.

undefined PelvEx Collaborative

Journal article  |  2020  |  Br J Surg

Management strategies for patients with advanced rectal cancer and liver metastases using modified Delphi methodology: results from the PelvEx Collaborative.

undefined PelvEx Collaborative

Journal article  |  2020  |  Colorectal Dis

AIM: A total of 15-20% of patients with rectal cancer have liver metastases on presentation. The management of these patients is c..

Management of primary and metastatic malignant small bowel obstruction, operate or palliate. A systematic review

Samuel P Banting, Peadar S Waters, Oliver Peacock, Vignesh Narasimhan, Andrew C Lynch, Jacob J McCormick, Satish K Warrier, Alexander G Heriot

Journal article  |  2020  |  ANZ JOURNAL OF SURGERY

BACKGROUND: The management of patients presenting with malignant small bowel obstruction is a challenging paradigm. The aim of thi..

Abdominoperineal excision in Australasia: clinical outcomes, predictive factors and recent trends of nonrestorative rectal cancer surgery

N Smith, PS Waters, O Peacock, JC Kong, AC Lynch, JJ McCormick, A Heriot, SK Warrier

Journal article  |  2020  |  COLORECTAL DISEASE

AIM: The decision to perform an abdominoperineal excision (APR) rather than restorative bowel resection relies on a number of clin..

Robotic multivisceral pelvic resection: experience from an exenteration unit

N Smith, DG Murphy, N Lawrentschuk, J McCormick, A Heriot, S Warrier, AC Lynch

Journal article  |  2020  |  TECHNIQUES IN COLOPROCTOLOGY

BACKGROUND: Pelvic exenteration remains a viable and effective treatment option for the management of locally advanced or recurren..

Robotic transanal minimally invasive surgery - technical, oncological and patient outcomes from a single institution

EJ Baker, PS Waters, O Peacock, V Narasimhan, T Larach, J McCormick, AG Heriot, S Warrier, C Lynch

Journal article  |  2020  |  COLORECTAL DISEASE

AIM: Robotic transanal minimally invasive surgery (R-TAMIS) is gaining traction around the globe as an alternative to laparoscopic..

Germline whole exome sequencing of a family with appendiceal mucinous tumours presenting with pseudomyxoma peritonei

Mei Sim Lung, Catherine A Mitchell, Maria A Doyle, Andrew C Lynch, Kylie L Gorringe, David DL Bowtell, Ian G Campbell, Alison H Trainer

Journal article  |  2020  |  BMC CANCER

BACKGROUND: Familial cases of appendiceal mucinous tumours (AMTs) are extremely rare and the underlying genetic aetiology uncertai..